SMTL ID : 2lzg.1

NMR Structure of Mdm2 (6-125) with Pip-1

Coordinates

PDB Format

Method

SOLUTION NMR

Oligo State

monomer

Ligands

1 x 13Q: [(3R,5R,6S)-5-(3-CHLOROPHENYL)-6-(4-CHLOROPHENYL)-1-(CYCLOPROPYLMETHYL)-2-OXOPIPERIDIN-3-YL]ACETIC ACID(Non-covalent)

13Q.1: 15 residues within 4Å: Chain A: V.14, T.15, T.16, L.54, L.57, G.58, I.61, M.62, Y.67, F.91, V.93, K.94, H.96, I.99, Y.100 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:V.14, A:L.54, A:I.61, A:Y.67, A:V.93 Salt bridges: A:H.96 pi-Stacking: A:H.96

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Michelsen, K. et al., Ordering of the N-Terminus of Human MDM2 by Small Molecule Inhibitors. J.Am.Chem.Soc. (2012)

Release Date

2012-11-07

Peptides

E3 ubiquitin-protein ligase Mdm2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase Mdm2

Related Entries With Identical Sequence